KCNV2相关视网膜病变:遗传学、电生理与临床病程
这项国际多中心队列研究纳入117例KCNV2相关视网膜病变患者,平均发病年龄3.9岁,所有患者12岁前出现症状,视力下降普遍存在。全视野ERG显示特征性波形,定量评估显示周边视网膜功能大致稳定,但视功能损害严重,凸显新疗法试验的未满足需求。
要点
- KCNV2相关视网膜病变患者均在12岁前出现症状,平均发病年龄3.9岁。
- 全视野ERG具有特征性波形,为诊断提供关键依据。
- 随访8.4年,BCVA平均从0.81降至0.90 logMAR,提示视功能进行性损害。
核心结论
- 全视野ERG对KCNV2相关视网膜病变具有诊断价值,并与周边视网膜功能大致稳定相一致。
- 该病临床表型严重,凸显对新疗法临床试验的未满足需求。
研究设计与样本
- 多中心国际临床队列研究,纳入117例儿童和成人KCNV2相关视网膜病变患者。
- 回顾临床记录和分子遗传学检测,并按国际标准记录和量化全视野ERG。
主要发现
- 共鉴定230个疾病相关等位基因,对应75种KCNV2变异,其中28种为新变异。
- 平均发病年龄3.9岁,所有患者12岁前出现症状(范围0-11岁)。
- 所有患者均有视力下降,其他常见症状包括色觉减退(78.6%)、畏光(53.5%)、夜盲(43.6%)和眼球震颤(38.6%)。
- 平均随访8.4年,平均BCVA(±SD)从0.81±0.27降至0.90±0.31 logMAR。
- 与对照相比,暗适应0.01 ERG、暗适应10 ERG a波、LA 3.0 30 Hz和LA3 ERG b波的平均振幅分别降低55%、21%、48%和74%,峰值时间在6个十年间保持稳定。
关键数值与推荐
- 全视野ERG显示特征性波形特征,可作为诊断依据。
- 定量评估显示ERG振幅和峰值时间范围较宽,年龄相关下降速率与对照组无法区分。
临床怎么用
- 对疑似KCNV2相关视网膜病变患者,应行全视野ERG检查以识别特征性波形。
- 结合分子遗传学检测可明确KCNV2变异,指导遗传咨询。
- 长期随访需关注视力进行性下降,目前尚无特效治疗,可考虑临床试验入组。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate genetics, electrophysiology, and clinical course of KCNV2-associated retinopathy in a cohort of children and adults. STUDY DESIGN: This was a multicenter international clinical cohort study. METHODS: Review of clinical notes and molecular genetic testing. Full-field electroretinography (ERG) recordings, incorporating the international standards, were reviewed and quantified and compared with age and recordings from control subjects. RESULTS: In total, 230 disease-associated alleles were identified from 117 patients, corresponding to 75 different KCNV2 variants, with 28 being novel. The mean age of onset was 3.9 years old. All patients were symptomatic before 12 years of age (range, 0-11 years). Decreased visual acuity was present in all patients, and 4 other symptoms were common: reduced color vision (78.6%), photophobia (53.5%), nyctalopia (43.6%), and nystagmus (38.6%). After a mean follow-up of 8.4 years, the mean best-corrected visual acuity (BCVA ± SD) decreased from 0.81 ± 0.27 to 0.90 ± 0.31 logarithm of minimal angle of resolution. Full-field ERGs showed pathognomonic waveform features. Quantitative assessment revealed a wide range of ERG amplitudes and peak times, with a mean rate of age-associated reduction indistinguishable from the control group. Mean amplitude reductions for the dark-adapted 0.01 ERG, dark-adapted 10 ERG a-wave, and LA 3.0 30 Hz and LA3 ERG b-waves were 55%, 21%, 48%, and 74%, respectively compared with control values. Peak times showed stability across 6 decades. CONCLUSION: In KCNV2-associated retinopathy, full-field ERGs are diagnostic and consistent with largely stable peripheral retinal dysfunction. Report 1 highlights the severity of the clinical phenotype and established a large cohort of patients, emphasizing the unmet need for trials of novel therapeutics.
引用
- Georgiou M, Robson AG, Fujinami K, et al. KCNV2-Associated Retinopathy: Genetics, Electrophysiology, and Clinical Course-KCNV2 Study Group Report 1. Am J Ophthalmol. 2020. PMID: 33309813. doi:10.1016/j.ajo.2020.11.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。